Human Immunodeficiency Virus Diagnosis After a Syphilis, Gonorrhea, or Repeat Diagnosis Among Males Including non–Men Who Have Sex With Men: What Is the Incidence?

BACKGROUND: The release of the first drug for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) in 2012 marked the beginning of a new era of HIV prevention. Although PrEP is highly efficacious, identifying and ultimately increasing uptake among the highest risk male subgroups remains...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilchin, Carla, Schumacher, Christina M., Psoter, Kevin J., Humes, Elizabeth, Muvva, Ravikiran, Chaulk, Patrick, Checkley, William, Jennings, Jacky M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
The Real World of STD Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426356/
https://www.ncbi.nlm.nih.gov/pubmed/30870326
http://dx.doi.org/10.1097/OLQ.0000000000000964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426356/
https://www.ncbi.nlm.nih.gov/pubmed/30870326
http://dx.doi.org/10.1097/OLQ.0000000000000964

Ejemplares similares